Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 2, 2026, Abivax S.A. (ABVX) has a Wall Street consensus price target of $142.50, based on estimates from 8 covering analysts. With the stock currently trading at $121.28, this represents a potential upside of +17.5%. The company has a market capitalization of $9.59B.
Analyst price targets range from a low of $110.00 to a high of $176.00, representing a 46% spread in expectations. The median target of $142.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 8 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, ABVX trades at a trailing P/E of -36.7x. Analysts expect EPS to grow +43.4% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how ABVX stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonAbivax S.A. (ABVX) has a consensus 12-month price target of $142.5, implying 17.5% upside from $121.28. The 8 analysts covering ABVX see moderate appreciation potential.
ABVX has a consensus rating of "Buy" based on 8 Wall Street analysts. The rating breakdown is predominantly bullish, with 8 Buy/Strong Buy ratings. The consensus 12-month price target of $142.5 implies 17.5% upside from current levels.
ABVX's current price is $121.28 with a consensus target of $142.5 (17.5% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $176 for ABVX, while the most conservative target is $110. The consensus of $142.5 represents the median expectation. These targets typically reflect 12-month expectations.
ABVX is moderately covered, with 8 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 8 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ABVX stock forecast based on 8 Wall Street analysts shows a consensus price target of $142.5, with estimates ranging from $110 (bear case) to $176 (bull case). The median consensus rating is "Buy".
Wall Street analysts are optimistic on ABVX, with a "Buy" consensus rating and $142.5 price target (17.5% upside). 8 of 8 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ABVX analyst price targets range from $110 to $176, a 46% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $142.5 consensus represents the middle ground.